Debio 1143 and High-Dose Cisplatin Chemoradiotherapy in High-Risk Locoregionally Advanced Squamous Cell Carcinoma of the Head and Neck: A Double-Blind, Multicentre, Randomised, Phase 2 Study

home / publications / supplement / debio-1143-and-high-dose-cisplatin-chemoradiotherapy-in-high-risk-locoregionally-advanced-squamo
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo